Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Relay Therapeutics, Inc. (RLAY) had Non-Operating Income/Expense of $5.74M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$7.00M |
|
$-54.89M |
|
-- |
|
$7.00M |
|
$67.63M |
|
$-60.63M |
|
|
Non-Operating Income/Expense |
$5.74M |
$-54.89M |
|
$-54.89M |
|
$-54.89M |
|
$-54.89M |
|
$-54.89M |
|
$-54.89M |
|
$-60.63M |
|
$-60.89M |
|
171.59M |
|
171.59M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$578.28M |
|
$1.73M |
|
$43.05M |
|
$621.33M |
|
$25.58M |
|
-- |
|
$28.69M |
|
$54.27M |
|
$567.06M |
|
$567.06M |
|
$567.06M |
|
173.87M |
|
| Cash Flow Statement Financials | |
$-235.46M |
|
$192.80M |
|
$1.60M |
|
$126.41M |
|
$85.35M |
|
$-41.05M |
|
$62.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-866.28% |
|
-866.28% |
|
-- |
|
-784.25% |
|
-784.25% |
|
$-235.87M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-9.68% |
|
-9.68% |
|
-8.83% |
|
-9.68% |
|
$3.26 |
|
$-1.37 |
|
$-1.37 |
|